IP Library Granted Patent US 9,353,393
Granted Patent B2
US 9,353,393 · App. 13/446,474 · Granted May 31, 2016

Methods and kits for reducing non-specific nucleic acid amplification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,353,393
App. No.
13/446,474
Granted
May 31, 2016
Kind
B2
Abstract

Methods and kits for efficient amplification of nucleic acids are provided. The disclosure generally relates to methods and kits for nucleic acid amplification of target nucleic acids of interest. The methods described herein promote the synthesis of the target nucleic acid (i.e., template nucleic acid) by reducing the production of undesirable primer-dimer structures and chimeric nucleic acid products during the amplification process by using novel modified primers.

Claims (10)

1. A method for amplifying a nucleic acid comprising:

a) providing a nucleic acid template;

b) contacting the nucleic acid template with a reaction solution comprising a DNA polymerase, deoxyribonucleoside triphosphates, and a primer with a 3′ end and a 5′ end, wherein the primer comprises a plurality of nucleotide analogues, wherein one or more nucleotide analogues of the plurality of nucleotide analogues increases the melting temperature (T m ) of the primer, one or more nucleotide analogues of the plurality of nucleotide analogues prevents primer-dimer formation,

and at least two nucleotide analogues of the plurality of nucleotide analogues are not a 2-amino-locked nucleic acid (LNA) nucleotide or a 2-thio-LNA nucleotide, and wherein one of the nucleotide analogues is 2-amino-deoxyadenosine (2-amino-dA) and one of the nucleotide analogues is 2-thio-deoxythymidine (2-thio-dT), and the 2-amino-dA increases the T m of the primer and both the 2-amino-dA and the 2-thio-dT prevent primer-dimer formation, and wherein the primer is a hexamer having the general structure of (+N)(+N)(atN)(atN)(atN)*N, wherein N represents a nucleotide having a nucleobase of cytosine, guanine, adenine, or thymine, wherein (+N) is the 5′ end nucleotide and *N is the 3′ end nucleotide of the hexamer, and wherein “+” indicates an LNA that precedes a nucleotide base, (atN) represents a random mixture of 2-amino-dA, deoxycytidine (dC), deoxyguanosine (dG), and 2-thio-dT, and “*” represents a phosphorothioate linkage; and

c) amplifying the nucleic acid template.

2. The method of claim 1 , wherein amplifying the nucleic acid template is performed under isothermal conditions.

3. The method of claim 1 , wherein amplifying the nucleic acid template is performed under high stringency conditions.

4. The method of claim 1 , wherein the DNA polymerase is phi29 DNA polymerase.

5. The method of claim 1 , wherein amplifying the nucleic acid template comprises a rolling circle amplification (RCA) or a multiple displacement amplification (MDA).

6. The method of claim 1 , wherein the method permits amplification of a trace amount of the nucleic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 054300/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: GENERAL ELECTRIC COMPANY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 053981/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: NELSON, JOHN RICHARD; GROSSMANN, GREGORY ANDREW; DUTHIE, ROBERT SCOTT; SHAH, SONALI JAGDISH; HELLER, RYAN CHARLES
To: GENERAL ELECTRIC COMPANY
Reel/Frame 028141/0431 →